Stay updated on DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Sign up to get notified when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.
Latest website image capture
Clouds background image

Latest updates to the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s disease label and a related topics section linking to MedlinePlus Genetics were removed, reducing visibility of the condition being studied and access to related resources.
    Difference
    0.2%
    Check dated 2026-05-29T22:25:12.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A new revision label v3.5.4 was added and the previous label v3.5.3 was removed. This update reflects an adjustment to the page's version information.
    Difference
    0.1%
    Check dated 2026-05-15T14:30:03.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page’s displayed revision/version tag has been incremented from v3.5.2 to v3.5.3, indicating a site update rather than a change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T05:49:48.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; removed entries for Multiple myeloma, related topics, MedlinePlus Genetics, and Revision: v3.5.0.
    Difference
    0.2%
    Check dated 2026-04-17T02:17:34.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    UI/layout adjustments are visible, with some sections duplicated likely due to rendering. No new or removed critical trial details (eligibility criteria, outcomes, or study purpose) are evident in the changes.
    Difference
    0.1%
    Check dated 2026-04-02T14:47:46.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    Removed references to 'Multiple Myeloma' and to 'MedlinePlus Genetics' from the page's related topics. This reduces explicit disease context and cross-links that help users discover and understand the study.
    Difference
    0.2%
    Check dated 2026-03-26T03:29:18.000Z thumbnail image

Stay in the know with updates to DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma

Enter your email address, and we'll notify you when there's something new on the DARIA Trial: Daratumumab + Ixazomib in Multiple Myeloma page.